AeriSeal System for Lung Volume Reduction

NCT01051258 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 55

Last updated 2013-06-26

No results posted yet for this study

Summary

The purpose of this study is to evaluate the safety and efficacy of AeriSeal treatment in patients with advanced emphysema.

Conditions

  • Emphysema
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Pulmonary Emphysema
  • Lung Diseases

Interventions

DEVICE

AeriSeal System

AeriSeal System for Lung Volume Reduction

Sponsors & Collaborators

  • Aeris Therapeutics

    lead INDUSTRY

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-11-30
Primary Completion
2011-08-31
Completion
2013-04-30

Countries

  • Austria
  • France
  • Germany
  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01051258 on ClinicalTrials.gov